184 related articles for article (PubMed ID: 6415746)
1. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
McIntyre IM; Kuhn C; Demitriou S; Fucek FR; Stanley M
Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
[TBL] [Abstract][Full Text] [Related]
2. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
Meller E; Friedman E
Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
[TBL] [Abstract][Full Text] [Related]
3. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
Rubin EH; Wooten GF
Psychopharmacology (Berl); 1984; 84(2):217-20. PubMed ID: 6438680
[TBL] [Abstract][Full Text] [Related]
4. Dopamine metabolites and catalepsy after lithium and haloperidol.
Bowers MB; Rozitis A
Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
[TBL] [Abstract][Full Text] [Related]
5. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
Le Douarin C; Oblin A; Fage D; Scatton B
Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
[TBL] [Abstract][Full Text] [Related]
6. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
Tanimoto K; Maeda K; Chihara K
Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
Hernandez L; Baptista T; Hoebel BG
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S17-35. PubMed ID: 2097671
[TBL] [Abstract][Full Text] [Related]
8. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
van Oene JC; de Vries JB; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
[TBL] [Abstract][Full Text] [Related]
10. Effects of prenatal cocaine exposure on haloperidol-induced increases in prolactin release and dopamine turnover in weanling, periadolescent, and adult offspring.
Goodwin GA; Rajachandran L; Moody CA; Francis R; Kuhn CM; Spear LP
Neurotoxicol Teratol; 1995; 17(4):507-14. PubMed ID: 7565497
[TBL] [Abstract][Full Text] [Related]
11. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
Olgiati VR; Algeri S; Stramentinoli G
Pharmacol Res Commun; 1987 Mar; 19(3):231-40. PubMed ID: 3602044
[TBL] [Abstract][Full Text] [Related]
13. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
Agut J; Coviella IL; Wurtman RJ
Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
15. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
Reches A; Jackson-Lewis V; Fahn S
Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824
[TBL] [Abstract][Full Text] [Related]
16. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
Westerink BH; Spaan SJ
J Neurochem; 1982 Mar; 38(3):680-6. PubMed ID: 7057187
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic lithium administration on dopamine metabolism in rat striatum.
Hesketh JE; Nicolaou NM; Arbuthnott GW; Wright AK
Psychopharmacology (Berl); 1978 Mar; 56(2):163-6. PubMed ID: 25454
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
19. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
Bacopoulos NG; Roth RH
Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
